145 related articles for article (PubMed ID: 22868972)
21. Six-year mortality rates of patients in methadone and buprenorphine maintenance therapy: results from a nationally representative cohort study.
Soyka M; Träder A; Klotsche J; Backmund M; Bühringer G; Rehm J; Wittchen HU
J Clin Psychopharmacol; 2011 Oct; 31(5):678-80. PubMed ID: 21881461
[No Abstract] [Full Text] [Related]
22. Opioid addicted buprenorphine injectors: drug use during and after 12-weeks of buprenorphine-naloxone or methadone in the Republic of Georgia.
Piralishvili G; Otiashvili D; Sikharulidze Z; Kamkamidze G; Poole S; Woody GE
J Subst Abuse Treat; 2015 Mar; 50():32-7. PubMed ID: 25456093
[TBL] [Abstract][Full Text] [Related]
23. [Methadone substitution treatment for heroin addiction: a program assessment in Colombia].
Zapata MA; Giraldo LF
Adicciones; 2012; 24(1):69-75. PubMed ID: 22508019
[TBL] [Abstract][Full Text] [Related]
24. Methadone therapy for opioid dependence.
Krambeer LL; von McKnelly W; Gabrielli WF; Penick EC
Am Fam Physician; 2001 Jun; 63(12):2404-10. PubMed ID: 11430455
[TBL] [Abstract][Full Text] [Related]
25. Methadone maintenance therapy as evidence based drug abuse planning in developed countries: can developing countries afford and learn from this experience?
Nsimba SE
East Afr J Public Health; 2010 Mar; 7(1):54-7. PubMed ID: 21413573
[TBL] [Abstract][Full Text] [Related]
26. Duration of methadone maintenance treatment during pregnancy and pregnancy outcome parameters in women with opiate addiction.
Peles E; Schreiber S; Bloch M; Dollberg S; Adelson M
J Addict Med; 2012 Mar; 6(1):18-23. PubMed ID: 21817914
[TBL] [Abstract][Full Text] [Related]
27. Outcome evaluation of the opioid agonist maintenance treatment in Iran.
Esmaeili HR; Ziaddinni H; Nikravesh MR; Baneshi MR; Nakhaee N
Drug Alcohol Rev; 2014 Mar; 33(2):186-93. PubMed ID: 24428135
[TBL] [Abstract][Full Text] [Related]
28. Methadone as social control: institutionalized stigma and the prospect of recovery.
Harris J; McElrath K
Qual Health Res; 2012 Jun; 22(6):810-24. PubMed ID: 22232295
[TBL] [Abstract][Full Text] [Related]
29. A comparison of characteristics and outcomes of opioid-dependent patients initiating office-based buprenorphine or methadone maintenance treatment.
Fingerhood MI; King VL; Brooner RK; Rastegar DA
Subst Abus; 2014; 35(2):122-6. PubMed ID: 24821346
[TBL] [Abstract][Full Text] [Related]
30. Low risk for hepatitis C seroconversion in methadone maintenance treatment.
Peles E; Schreiber S; Rados V; Adelson M
J Addict Med; 2011 Sep; 5(3):214-20. PubMed ID: 21844836
[TBL] [Abstract][Full Text] [Related]
31. Misconceptions predict dropout and poor adherence prospectively among newly admitted first-time methadone maintenance treatment clients in Guangzhou, China.
Gu J; Xu H; Lau JT; Hao Y; Zhong Y; Fan L; Zhao Y; Hao C; Ling W
Addiction; 2012 Sep; 107(9):1641-9. PubMed ID: 22360534
[TBL] [Abstract][Full Text] [Related]
32. Methadone treatment practices and outcome for opiate addicts treated in drug clinics and in general practice: results from the National Treatment Outcome Research Study.
Gossop M; Marsden J; Stewart D; Lehmann P; Strang J
Br J Gen Pract; 1999 Jan; 49(438):31-4. PubMed ID: 10622013
[TBL] [Abstract][Full Text] [Related]
33. [Problems with maintenance therapy in opiate dependence and the clinical importance of methadone].
Wilczek H
Cas Lek Cesk; 1998 Nov; 137(23):725-8. PubMed ID: 9990177
[TBL] [Abstract][Full Text] [Related]
34. Does methadone maintenance treatment based on the new national guidelines work in a primary care setting?
Keen J; Oliver P; Rowse G; Mathers N
Br J Gen Pract; 2003 Jun; 53(491):461-7. PubMed ID: 12939891
[TBL] [Abstract][Full Text] [Related]
35. The impact of benzodiazepine use on methadone maintenance treatment outcomes.
Brands B; Blake J; Marsh DC; Sproule B; Jeyapalan R; Li S
J Addict Dis; 2008; 27(3):37-48. PubMed ID: 18956528
[TBL] [Abstract][Full Text] [Related]
36. Problem drinking in relation to treatment outcome among opiate addicts in methadone maintenance treatment.
Stenbacka M; Beck O; Leifman A; Romelsjö A; Helander A
Drug Alcohol Rev; 2007 Jan; 26(1):55-63. PubMed ID: 17364837
[TBL] [Abstract][Full Text] [Related]
37. A 12-month evaluation of health-related quality of life outcomes of methadone maintenance program in a rural Malaysian sample.
Lua PL; Talib NS
Subst Use Misuse; 2012 Aug; 47(10):1100-5. PubMed ID: 22545914
[TBL] [Abstract][Full Text] [Related]
38. Use of a 'microecologic technique' to study crime incidents around methadone maintenance treatment centers - a response: The journal publishes both invited and unsolicited letters.
Gupta R; Sarkar S; Balhara YP
Addiction; 2012 Oct; 107(10):1883. PubMed ID: 22831569
[No Abstract] [Full Text] [Related]
39. Depression in methadone maintenance treatment patients: rate and risk factors.
Peles E; Schreiber S; Naumovsky Y; Adelson M
J Affect Disord; 2007 Apr; 99(1-3):213-20. PubMed ID: 17055063
[TBL] [Abstract][Full Text] [Related]
40. Risk factors for kidney disease among HIV-1 positive persons in the methadone program.
Matłosz B; Pietraszkiewicz E; Firląg-Burkacka E; Grycner E; Horban A; Kowalska JD
Clin Exp Nephrol; 2019 Mar; 23(3):342-348. PubMed ID: 30218298
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
